FATE - Wall Street Estimates - Fate Therapeutics, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 1.045

-6.7 %

$ 119 M

Market Cap

-0.64

P/E

Price Target Average

446.82%

Revenue Forecast Estimate

--11.19%

EBIT Estimate

38.41%

Net Income Estimate

5.39%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Fate Therapeutics, Inc.

Wall Street analysts predict an average 1-year price target for FATE of $5.71 , with forecasts ranging from a low of $4 to a high of $9 .

FATE Lowest Price Target Wall Street Target

4 USD 282.78%

FATE Average Price Target Wall Street Target

5.71 USD 446.82%

FATE Highest Price Target Wall Street Target

9 USD 761.24%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free